• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY CMW - 9610921 SMARTSET HV BONE CEMENT 40G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY CMW - 9610921 SMARTSET HV BONE CEMENT 40G; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 3092-040
Device Problems Loss of or Failure to Bond (1068); Loose or Intermittent Connection (1371)
Patient Problems Pain (1994); Swelling (2091); Ambulation Difficulties (2544); No Code Available (3191); Swelling/ Edema (4577)
Event Date 09/25/2018
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Occupation: is a non-healthcare professional.(b)(4).
 
Event Description
Right knee revised due to pain, swelling, difficulty walking, and loosening of tibial tray at the cement to implant interface.Doi: (b)(6) 2017 dor: (b)(6) 2018.
 
Manufacturer Narrative
Investigation summary: no device associated with this report was received for examination.X-ray images were included for review.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch , a follow-up medwatch, will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
Medical records/billing records were reviewed: on (b)(6) 2018, the patient had a revision right total knee arthroplasty to address loosening tibial tray at the implant/cement interface, pain, effusion, clunking and inability to perform his normal function.The femoral component was noted to be loosened ¿was cleaned and re-cemented¿, the patella was noted to be well fixed and was retained.On (b)(6) 2018, the patient had a revision left total knee arthroplasty to address loosening of the tibial tray at the cement/implant interface, pain, swelling, and difficulty with walking.The patella and femoral components were noted to be well-fixed and were retained.The insert was removed without allegation of deficiency.(sticker page 46 of 97) depuy tibial tray and insert were used as well as competitor cement x2 were used during this procedure.On (b)(6) 2019, the patient had a revision right total knee arthroplasty to address loose right total knee.The indications for surgery included that the patient had a previous revision for aseptic loosening of his tibial plateau.The patient now has loosening of the femoral component as well as the patellar component, severe popping and snapping and difficult ambulation.During the procedure, the surgeon observed loosening of the femoral component and patella, with no interface provided.The tibial tray was noted to be well fixed.(sticker page 55 of 97) depuy patella, insert, and femoral components along with competitor cement x2 were used during this procedure.On (b)(6) 2019, the patient had a revision left total knee arthroplasty to address failed left total knee arthroplasty and loose left total knee arthroplasty.The indications for surgery included: one bag of depuy cement used for both knees during initial implantation, which led to early failure and has had a previous revision for loose tibial.Prior medical records noted the patient was experiencing instability, and pain.During the current revision the surgeon reported that the femoral component and patella were loose, no interface provided.(sticker page 43 of 97) depuy femoral component, patella, and insert, along with competitor cement x2 were used during this procedure.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: added: b5.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
Medical and billing records received and were reviewed: office notes (b)(6) 2019 indicate the patient is experiencing swelling, popping, instability and pain of the left knee.He is also experiencing swelling, pain, numbness and instability in the right knee and feelings of crunching and cracking.Current treatment includes oral pain medication, physical therapy, knee braces and nerve blocks.No evidence of additional revision of products.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.X-ray images were included for review.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: the device associated with this report was not returned to depuy synthes for evaluation.The photo and x-ray investigation found nothing indicative of a device nonconformance or loosening.The photograph attached to the complaint was reviewed and determined that the photo did not show any information that would aid in the investigation, therefore the reported allegation cannot be confirmed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSET HV BONE CEMENT 40G
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY CMW - 9610921
cornford rd
blackpool IN FY4 4 QQ
UK  FY4 4QQ
Manufacturer (Section G)
DEPUY CMW ¿ 9610921 
cornford rd
blackpool FY4 4 QQ
UK   FY4 4QQ
Manufacturer Contact
kara ditty-bovard
700 orthopaedic drive
warsaw, IN 46582-0988
6107428552
MDR Report Key8030470
MDR Text Key125863476
Report Number1818910-2018-74242
Device Sequence Number1
Product Code LOD
UDI-Device Identifier10603295168331
UDI-Public10603295168331
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K023012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2019
Device Model Number3092-040
Device Catalogue Number3092040
Device Lot Number8484058
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/02/2018
Initial Date FDA Received11/01/2018
Supplement Dates Manufacturer Received11/19/2018
12/04/2020
03/17/2021
03/31/2021
03/27/2023
04/05/2023
Supplement Dates FDA Received11/19/2018
12/17/2020
04/07/2021
04/20/2021
03/29/2023
04/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/21/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MBT CEM KEEL TIB TRAY SZ5; PFC SIGMARP STB TB IN 5 10.0; PFC*SIGMA/OV/DOME PAT 3PEG,41; SIGMA PS CEM FEM SZ5 L
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
Patient Weight109 KG
-
-